Targeting autophagic pathways for cancer drug discovery

Chinese Journal of Cancer

Volumn 32, Issue 3, 2013, Pages 113-120

  Liu, Bo ^a   Bao, Jin Ku ^a   Yang, Jin Ming ^b   Cheng, Yan ^b  

^a SICHUAN UNIVERSITY   (China)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Autophagy; Cancer; Cell death; Drug discovery; Survival

Indexed keywords

ARSENIC TRIOXIDE; BECLIN 1; CHLOROQUINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMATINIB; MAMMALIAN TARGET OF RAPAMYCIN; MEPACRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT LECTIN; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TEMOZOLOMIDE; VORINOSTAT;

APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; AUTOPHAGY RELATED GENE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; DRUG CYTOTOXICITY; DRUG POTENTIATION; GASTROINTESTINAL STROMAL TUMOR; GENE; GLIOMA; HUMAN; LYSOSOME; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CHLOROQUINE; DRUG DISCOVERY; HUMANS; MEMBRANE PROTEINS; MOLECULAR TARGETED THERAPY; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84874881784     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.012.10010     Document Type: Review

References (73)

1. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science, 2000, 290:1717-1721.
2. Liu B, Cheng Y, Liu Q, et al. Autophagic pathways as new targets for cancer drug development. Acta Pharmacol Sin, 2010,31:1154-1164.
3. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science, 2004,306:990-995.
4. Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature, 2008,451:1069-1075
5. Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol, 2010,12: 814-822.
6. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell, 2008,132:27-42.
7. Klionsky DJ. Cell biology: regulated self-cannibalism. Nature, 2004,431:31-32.
8. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell, 2004,6:463-477.
9. Hannigan AM, Gorski SM. Macroautophagy: the key ingredient to a healthy diet? Autophagy, 2009,5:140-151.
10. Rubinsztein DC, Gestwicki JE, Murphy LO, et al. Potential therapeutic applications of autophagy. Nat Rev Drug Discov, 2007,6:304-312.
11. Huang J, Klionsky DJ. Autophagy and human disease. Cell Cycle, 2007,6:1837-1849.
12. Kevin M, Luo SQ, David CR. Cytoprotective roles for autophagy. Curr Opin Cell Biol, 2010,22:206-211.
13. Wang SY, Yu QJ, Zhang RD, et al. Core signaling pathways of survival/death in autophagy-re lated cancer networks. Int J Biochem Cell Biol, 2011,43:1263-1266.
14. Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer, 2005, 5: 886-897.
15. Morselli E, Galluzzi L, Kepp O, et al. Antiand pro-tumor functions of autophagy. Biochim Biophys Acta, 2009,1793: 1524-1532.
16. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene, 2004,23:2891-2906.
17. Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer, 2007,7:961-967.
18. Dalby KN, Tekedereli I, Lopez-B erestein G, et al. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy, 2010,6:322-329.
19. Elisabeth AC, Pietri P, Marja J. Apoptosis and autophagy: targeting autophagy signaling in cancer cells-'trick or treats'? FEBS J, 2009,276:6084-6096.
20. Bhutia SK, Kegelman TP, Das SK, et al. Astrocyte elevated gene-1 activates AMPK in response to cellular metabolic stress and promotes protective autophagy. Autophagy, 2011,7:547-548.
21. Yang J, Takahashi Y, Cheng E, et al. GSK-3beta promotes cell survival by modulating Bif-1dependent autophagy and cell death. J Cell Sci, 2010,123:861-870.
22. Wu WK, Cho CH, Lee CW, et al. Acroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells. Autophagy, 2010, 6:228-238.
23. Loewith R, Jacinto E, Wullschleger S, et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell, 2002,10:457-468.
24. Jung CH, Ro SH, Cao J, et al. Mtor regulation of autophagy. FEBS Lett, 2010,584:1287-1295.
25. Manning BD, Tee AR, Logsdon MN, et al. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-ki nase/akt pathway. Mol Cell, 2002,10:151-162.
26. Inoki K, Li Y, Zhu T, et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol, 2002,4:648-657.
27. Ma L, Chen Z, Erdjument-B romage H, et al. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell, 2005,121: 179-193.
28. Suzuki K, Kubota Y, Sekito T, et al. Hierarchy of Atg proteins in pre-au tophagosomal structure organization. Genes Cells, 2007,12:209-218.
29. Gingras AC, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev, 2001,15:807-826.
30. Krejci O, Wunderlich M, Geiger H, et al. P53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-in duced death. Blood, 2008,111:2190-2199.
31. Ertmer A, Huber V, Gilch S, et al. The anticancer drug imatinib induces cellular autophagy. Leukemia, 2007,21:936-942
32. Crighton D, Wilkinson S, O'Prey J, et al. DRAM, a p53induced modulator of autophagy, is critical for apoptosis. Cell, 2006,126:121-134.
33. Tasdemir E, Maiuri MC, Galluzzi L, et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol, 2008,10:676-687.
34. Young AR, Narita M, Ferreira M, et al. Autophagy mediates the mitotic senescence transition. Genes Dev, 2009,23:798-803.
35. Cao Y, Klionsky DJ. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res, 2007,17:839-849.
36. Maycotte P, Thorburn A. Autophagy and cancer therapy. Cancer Biol Ther, 2011,11: 127-137.
37. Furuya N, Yu J, Byfield M, et al. The evolutionarily conserved domain of Beclin-1 is required for Vps34 binding, autophagy and tumor-suppressor function. Autophagy, 2005, 1:46-52.
38. Maiuri MC, Criollo A, Tasdemir E, et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2 /Bcl-X (L). Autophagy, 2007, 3:374-376.
39. Kang R, Zeh HJ, Lotze MT, et al. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ, 2011,18: 571-580.
40. He C, Levine B. The Beclin 1 interactome. Curr Opin Cell Biol, 2010,22:140-149.
41. Mazure NM, Pouyssegur J. Hypoxia-induced autophagy: cell death or cell survival? Curr Opin Cell Biol, 2010,22: 177-180.
42. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene, 2004,23:2891-2906.
43. Cheng Y, Ren X, Zhang Y, et al. Eef-2 kinase dictates cross talk between autophagy and apoptosis induced by Akt inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res, 2011,71: 2654-2663.
44. Turcotte S, Giaccia AJ. Targeting cancer cells through autophagy for anticancer therapy. Curr Opin Cell Biol, 2010,22: 246-251.
45. Chen S, Rehman SK, Zhang W, et al. Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta, 2010,1806:220-229.
46. Takeuchi H, Kondo Y, Fujiwara K, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-ki nase/protein kinase B inhibitors. Cancer Res, 2005,65:3336-3346.
47. Fujiwara K, Iwado E, Mills GB, et al. Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy. Int J Oncol, 2007, 31:753-760.
48. Amaravadi RK, Yu D, Lum JJ, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest, 2007, 117:326-336.
49. Maclean KH, Dorsey FC, Cleveland JL, et al. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest, 2008, 118:79-88.
50. Poole B, Ohkuma S. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol, 1981, 90:665-669.
51. Glaumann H, Ahlberg J. Comparison of different autophagic vacuoles with regard to ultrastructure, enzymatic composition, and degradation capacity-formation of crinosomes. Exp Mol Pathol, 1987, 47:346-362.
52. Bellodi C, Lidonnici MR, Hamilton A, et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest, 2009,119:1109-1123.
53. Gupta A, Roy S, Lazar AJ, et al. Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST). Proc Natl Acad Sci U S A, 2010,107:1433314338.
54. Amaravadi RK, Yu D, Lum JJ, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest, 2007,117:326-336.
55. Cheng Y, Qiu F, Ye YC, et al. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells. FEBS J, 2009,276: 1291-1306.
56. Cheng Y, Li H, Ren X, et al. Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition. PLoS One, 2010,5: e9715.
57. de Medina P, Payre B, Boubekeur N, et al. Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism. Cell Death Differ, 2009,16:1372-1384.
58. Younes A. Therapeutic activity of mTOR-inhibitors in mantle cell lymphoma: clues but no clear answers. Autophagy, 2008,4: 707-709.
59. Kim KW, Hwang M, Moretti L, et al. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy, 2008,4:659-668.
60. Kanzawa T, Zhang L, Xiao L, et al. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene, 2005,24: 980-991.
61. Fu LL, Zhou CC, Yao S, et al. Plant lectins: targeting programmed cell death pathways as anti-tumor agents. Int J Biochem Cell Biol, 2011, 43:1442-1449.
62. Shao Y, Gao Z, Marks PA, et al. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A, 2004,101:18030-18035.
63. Liu JJ, Lin M, Yu JY, et al. Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett, 2011, 300:105-114.
64. Liu B, Wu JM, Li J, et al. Polygonatum cyrtonema lectin induces murine fibrosarcoma L929 cell apoptosis and autophagy via blocking Ras-R af and PI3K-A kt signaling pathways. Biochimie, 2010,92:1934-1938.
65. Marks PA. Discovery and development of SAHA as an anticancer agent. Oncogene, 2007,26:1351-1356.
66. Wang SY, Yu QJ, Bao JK, et al. Polygonatum cyrtonema lectin: a potential antineoplastic drug targeting programmed cell death pathways. Biochem Biophys Res Commun, 2011,406: 497-500.
67. Miller WH Jr, Schipper HM, Lee JS, et al. Mechanisms of action of arsenic trioxide. Cancer Res, 2002,62:3893-3903.
68. Liu B, Cheng Y, Bian HJ, et al. Molecular mechanisms of polygonatum cyrtonema lectin induced apoptosis and autophagy in cancer cells. Autophagy, 2009, 5:253-255.
69. Kanzawa T, Zhang L, Xiao L, et al. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene, 2005, 24: 980-991.
70. Liu B, Cheng Y, Zhang B, et al. Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondria-m ediated ROS-p3 8-p5 3 pathway. Cancer Lett, 2009, 275:54-60.
71. Liu B, Min MW, Bao JK. Induction of apoptosis by Concanavalin A and its molecular mechanisms in cancer cells. Autophagy, 2009, 5:432-433.
72. Zhang X, Chen LX, Ouyang L, et al. Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents. Cell Proliferation, 2012. doi: 10.1111/j.1365-2184.2012.00833.x.
73. Fu LL, Wen X, Bao JK, et al. MicroRNA-m odulated autophagic signaling networks in cancer. Int J Biochem Cell Biol, 2012, 44: 733-736.